Venlafaxine Hydrochloride
- Product NDC
- 80425-0477
- Requested package NDC
- 80425-0477-2
- 11-digit product format
- 804250477
- Labeler code
- 80425
- Product ID
- 80425-0477_2d034ebe-1e07-6fe0-e063-6394a90a368b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- venlafaxine hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Advanced Rx of Tennessee, LLC
- Application
- NDA022104
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2025-01-30
- Substance
- VENLAFAXINE HYDROCHLORIDE
- Active strength
- 37.5 mg/1
- Pharmacologic classes
- Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N022104-001 | VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | EQ 37.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2008-05-20 |
| N022104-002 | VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | EQ 75MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2008-05-20 |
| N022104-003 | VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | EQ 150MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2008-05-20 |
| N022104-004 | VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | EQ 225MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2008-05-20 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N022104-001 | AB |
| N022104-002 | AB |
| N022104-003 | AB |
| N022104-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N022104-001 | VENLAFAXINE HYDROCHLORIDE | EQ 37.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2008-05-20 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022104-002 | VENLAFAXINE HYDROCHLORIDE | EQ 75MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2008-05-20 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022104-003 | VENLAFAXINE HYDROCHLORIDE | EQ 150MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2008-05-20 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022104-004 | VENLAFAXINE HYDROCHLORIDE | EQ 225MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2008-05-20 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N022104-001 | VENLAFAXINE HYDROCHLORIDE | EQ 37.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2008-05-20 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022104-002 | VENLAFAXINE HYDROCHLORIDE | EQ 75MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2008-05-20 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022104-003 | VENLAFAXINE HYDROCHLORIDE | EQ 150MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2008-05-20 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022104-004 | VENLAFAXINE HYDROCHLORIDE | EQ 225MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2008-05-20 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N022104-001 | VENLAFAXINE HYDROCHLORIDE | EQ 37.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2008-05-20 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022104-002 | VENLAFAXINE HYDROCHLORIDE | EQ 75MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2008-05-20 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022104-003 | VENLAFAXINE HYDROCHLORIDE | EQ 150MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2008-05-20 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022104-004 | VENLAFAXINE HYDROCHLORIDE | EQ 225MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2008-05-20 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022104-001 | VENLAFAXINE HYDROCHLORIDE | EQ 37.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2008-05-20 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022104-002 | VENLAFAXINE HYDROCHLORIDE | EQ 75MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2008-05-20 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022104-003 | VENLAFAXINE HYDROCHLORIDE | EQ 150MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2008-05-20 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022104-004 | VENLAFAXINE HYDROCHLORIDE | EQ 225MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2008-05-20 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N022104-001 | VENLAFAXINE HYDROCHLORIDE | EQ 37.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2008-05-20 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022104-002 | VENLAFAXINE HYDROCHLORIDE | EQ 75MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2008-05-20 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022104-003 | VENLAFAXINE HYDROCHLORIDE | EQ 150MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2008-05-20 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022104-004 | VENLAFAXINE HYDROCHLORIDE | EQ 225MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2008-05-20 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022104-001 | VENLAFAXINE HYDROCHLORIDE | EQ 37.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2008-05-20 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022104-002 | VENLAFAXINE HYDROCHLORIDE | EQ 75MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2008-05-20 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022104-003 | VENLAFAXINE HYDROCHLORIDE | EQ 150MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2008-05-20 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022104-004 | VENLAFAXINE HYDROCHLORIDE | EQ 225MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2008-05-20 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022104-001 | VENLAFAXINE HYDROCHLORIDE | EQ 37.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2008-05-20 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022104-002 | VENLAFAXINE HYDROCHLORIDE | EQ 75MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2008-05-20 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022104-003 | VENLAFAXINE HYDROCHLORIDE | EQ 150MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2008-05-20 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022104-004 | VENLAFAXINE HYDROCHLORIDE | EQ 225MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2008-05-20 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022104-001 | VENLAFAXINE HYDROCHLORIDE | EQ 37.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2008-05-20 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022104-002 | VENLAFAXINE HYDROCHLORIDE | EQ 75MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2008-05-20 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022104-003 | VENLAFAXINE HYDROCHLORIDE | EQ 150MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2008-05-20 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022104-004 | VENLAFAXINE HYDROCHLORIDE | EQ 225MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2008-05-20 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022104-001 | VENLAFAXINE HYDROCHLORIDE | EQ 37.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2008-05-20 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022104-002 | VENLAFAXINE HYDROCHLORIDE | EQ 75MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2008-05-20 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022104-003 | VENLAFAXINE HYDROCHLORIDE | EQ 150MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2008-05-20 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022104-004 | VENLAFAXINE HYDROCHLORIDE | EQ 225MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2008-05-20 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022104-001 | VENLAFAXINE HYDROCHLORIDE | EQ 37.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2008-05-20 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022104-002 | VENLAFAXINE HYDROCHLORIDE | EQ 75MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2008-05-20 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022104-003 | VENLAFAXINE HYDROCHLORIDE | EQ 150MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2008-05-20 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022104-004 | VENLAFAXINE HYDROCHLORIDE | EQ 225MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | RLD | 2008-05-20 | 5bbf6a4d5a75… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N022104-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022104-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022104-003 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022104-004 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N022104-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022104-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022104-003 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022104-004 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N022104-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022104-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022104-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022104-004 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022104-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022104-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022104-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022104-004 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N022104-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022104-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022104-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022104-004 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022104-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022104-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022104-003 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022104-004 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022104-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022104-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022104-003 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022104-004 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022104-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022104-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022104-003 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022104-004 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022104-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022104-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022104-003 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022104-004 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022104-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022104-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022104-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022104-004 | AB | 1 | 5bbf6a4d5a75… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Venlafaxine Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| VENLAFAXINE HYDROCHLORIDE | 37.5 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 7D7RX5A8MO | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 808751 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2cf6e6ad-7d00-0db1-e063-6394a90ab1ec | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 17db3736-056c-48b9-b0f4-00fccabb14e6 | Product name | 5 | 20251118 |
| 7be8b949-f2c0-bdd8-e89d-8af92c1b2ead | Product name | 9 | 20250224 |
| b1435b59-059c-404b-a587-53656bf80e17 | Product name | 1 | 20230314 |
| a62a50ac-1535-4461-9768-8ae703e2e9fb | Product name | 1 | 20210525 |
| 6005cd75-f7b1-d6be-3cb5-4bd30d5c4617 | Product name | 3 | 20190314 |
| 9514609b-a2a9-f8ec-6ba6-3f8e5ee89877 | Product name | 1 | 20140508 |
| bc07ef78-e82d-0c19-31f4-31f263780582 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0477-1 | Venlafaxine Hydrochloride | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | 2 | |
| 80425-0477-2 | Venlafaxine Hydrochloride | 60 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 60 | 2 | |
| 80425-0477-3 | Venlafaxine Hydrochloride | 90 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 90 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0477-1 | EA - Each | 80425-0477 | 39e5e5ca-6655-403e-ba4d-7e1084c67689 | 1 | 2025-03-04 |
| 80425-0477-2 | EA - Each | 80425-0477 | 13cdee5a-42f8-452b-8a42-91036a74a949 | 1 | 2025-03-04 |
| 80425-0477-3 | EA - Each | 80425-0477 | 4a0eebb3-a622-477f-b111-a35026b9e660 | 1 | 2025-03-04 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0477 | VENLAFAXINE HYDROCHLORIDE TABLET, EXTENDED RELEASE [ADVANCED RX OF TENNESSEE, LLC] | 2 | Current NDC, 3 package rows | 20250201_2cf6e6ad-7d00-0db1-e063-6394a90ab1ec.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | Trigen Laboratories, LLC | fdaed1c2-dd0a-4bf3-975a-86fe3e7f0c97 | 2025-07-31 | Boxed warning, Warnings, Adverse reactions | 022104 NDA022104 |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | Advanced Rx of Tennessee, LLC | 2cf6e6ad-7d00-0db1-e063-6394a90ab1ec | 2025-01-31 | Boxed warning, Warnings, Adverse reactions | 022104 NDA022104 80425-0477-2 80425-0477 80425047702 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 808751 | venlafaxine HCl 37.5 MG 24HR Extended Release Oral Tablet | PSN | 2cf6e6ad-7d00-0db1-e063-6394a90ab1ec | 2 |
| 808751 | 24 HR venlafaxine 37.5 MG Extended Release Oral Tablet | SCD | 2cf6e6ad-7d00-0db1-e063-6394a90ab1ec | 2 |
| 808751 | venlafaxine 37.5 MG (as venlafaxine hydrochloride) 24 HR Extended Release Oral Tablet | SY | 2cf6e6ad-7d00-0db1-e063-6394a90ab1ec | 2 |
| 808751 | venlafaxine 37.5 MG 24 HR Extended Release Oral Tablet | SY | 2cf6e6ad-7d00-0db1-e063-6394a90ab1ec | 2 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 80425-0477-2 | 80425047702 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (80425-0477-2) | 2025-01-30 | No | No | Current |